SCHEMBL7815

SCHEMBL7815

[CH]1NCC2CCCCC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14740988 1.00
SCHEMBL37649 0.95
SCHEMBL1477516 0.77 ALDH1A1 (0.33)
SCHEMBL1476914 0.77 ALDH1A1 (0.33)
SCHEMBL7283678 0.77 ALDH1A1 (0.33)
SCHEMBL5159 0.77 ALDH1A1 (0.33)
SCHEMBL24690865 0.75 ALDH1A1 (0.32)
SCHEMBL37993 0.75 ALDH1A1 (0.32)
SCHEMBL10873496 0.72
SCHEMBL14720581 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10950 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11958830-B2 Protease inhibitors, preparation, and uses thereof WESTLAKE PHARMACEUTICALS (HANGZHOU) CO., LTD. (CN) 2024-04-16 US claimed
US-20240101535-A1 DIHYDROISOQUINOLINONE DERIVATIVE AND APPLICATION THEREOF ETERN BIOPHARMA (SHANGHAI) CO., LTD. (CN) 2024-03-28 US claimed
EP-4320125-A1 PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER Bristol-Myers Squibb Company (US) 2024-02-14 EP claimed
WO-2024026061-A1 COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE BIOGEN MA INC. (US) 2024-02-01 WO claimed
US-20240018140-A1 MODIFIED IMIDAZOPYRIDINES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC (US) 2024-01-18 US claimed
CN-117396477-A Pyridyl-substituted oxoisoindoline compounds for the treatment of cancer 百时美施贵宝公司 2024-01-12 CN claimed
WO-2023225244-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE BIOGEN MA INC. (US) 2023-11-23 WO claimed
WO-2023220741-A1 ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF DICE MOLECULES SV, INC. (US) 2023-11-16 WO claimed
EP-4261211-A1 DIHYDROISOQUINOLINONE DERIVATIVE AND APPLICATION THEREOF Etern Biopharma (Shanghai) Co., Ltd. (CN) 2023-10-18 EP claimed
CN-116783188-A Dihydro-isoquinolone derivative and application thereof 上海奕拓医药科技有限责任公司 2023-09-19 CN claimed
EP-1196389-A1 N-HETEROCYCLIC DERIVATIVES WITH NEURONAL ACTIVITY Vertex Pharmaceuticals Incorporated (US) 2002-04-17 EP claimed
WO-2001002368-A1 N-HETEROCYCLIC DERIVATIVES WITH NEURONAL ACTIVITY VERTEX PHARMACEUTICALS INCORPORATED (US) 2001-01-11 WO claimed
EP-1056734-A2 SUBSTITUTED ALXOXYCARBONYL COMPOUNDS BAYER AG (DE) 2000-12-06 EP claimed
EP-0655056-B1 AZACYCLYL-TERMINATED N-(DIHYDROXY ALKYL)-ETHYNYL-ALANINE AMIDES FOR TREATMENT OF HYPERTENSION SEARLE & CO (US) 1999-12-01 EP claimed
WO-1999042457-A2 SUBSTITUTED ALXOXYCARBONYL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 1999-08-26 WO claimed
US-5780494-A RENIN INHIBITOR G. D. SEARLE & CO. (US) 1998-07-14 US claimed
EP-0655056-A1 PIPERIDINYL-TERMINATED N-(DIHYDROXY ALKYL)-ETHYNYL-ALANINE AMIDES FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1995-05-31 EP claimed
WO-1994004495-A1 PIPERIDINYL-TERMINATED N-(DIHYDROXY ALKYL)-ETHYNYL-ALANINE AMIDES FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1994-03-03 WO claimed
US-4638000-A HYPOTENSIVES, ANGIOTENSIN INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-01-20 US claimed
US-4548932-A ANGIOTENSIN INHIBITOR, HYPOTENSIVE AGENT TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-10-22 US claimed